NASDAQ: BDTX
Black Diamond Therapeutics Revenue

Black Diamond Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BDTX annual revenue was $0.0, with N/A growth year-over-year.

BDTX revenue history

Current Revenue
$0.0
Current Earnings
-$69.7M
Current Profit Margin
0%

Be the first to know when BDTX announces revenue.

BDTX Revenue History By Year

BDTX Yearly RevenueBDTX RevenueBDTX ChangeBDTX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Black Diamond Therapeutics Revenue FAQ

What was BDTX's revenue last quarter?

On Invalid Date, Black Diamond Therapeutics (NASDAQ: BDTX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Black Diamond Therapeutics's revenue was $0.00.

What was Black Diamond Therapeutics's revenue in 2024?

Black Diamond Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Black Diamond Therapeutics make in a day?

Based on Black Diamond Therapeutics annual revenue for the past five years, BDTX makes an average of $0.00 per day.

What was Black Diamond Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Black Diamond Therapeutics's revenue has grown null year over year. Black Diamond Therapeutics's revenue in the past year totaled $0.00.

How much does Black Diamond Therapeutics make in a year?

Black Diamond Therapeutics's revenue by year for the past five years is:
  • Black Diamond Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Black Diamond Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Black Diamond Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Black Diamond Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Black Diamond Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.